Detalhe da pesquisa
1.
Isolation and Maintenance of Tumor-Infiltrating Lymphocytes for Translational and Clinical Applications: Established Methods and New Developments.
Methods Mol Biol
; 2435: 43-71, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34993939
2.
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
J Immunother
; 41(9): 399-405, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29757889
3.
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Clin Cancer Res
; 24(18): 4416-4428, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848573
4.
A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes.
Front Immunol
; 8: 908, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28824634
5.
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.
Oncoimmunology
; 6(6): e1321187, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28680759
6.
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity.
Oncoimmunology
; 5(2): e1057386, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27057427
7.
Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.
Cancer Immunol Res
; 3(11): 1201-6, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216417
8.
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
Clin Cancer Res
; 18(24): 6758-70, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23032743
9.
TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
J Immunother
; 33(4): 371-81, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20386469